- Latest week
- 10 Jul 2026
- Close
- 116.500000
- Fair value
- 102.249705
- Next-week expectancy
- Undecided 48.44%
BIOG-B Chart Pack
BioGaia AB (publ)
Chart Summary
Over the latest 12 completed weeks ending 2026-07-10, BIOG-B rose 2.19%, moving from 114.00 to 116.50. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is -0.74 and has improved across the 12-week window. Market Dynamics is -0.53 on the latest week. Next-week expectancy is undecided at 48.44% based on similar historical setup states.
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 116.50
- 12-Week Change
- 2.19%
- Trend Signal
- Active
- Next-Week Expectancy
- Undecided 48.44%
- Signal Weeks
- 12 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- -0.74
- Market Dynamics
- -0.53
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 116.50
- 12-Week Change
- 2.19%
- Trend Signal
- Active
- Next-Week Expectancy
- Undecided 48.44%
- Signal Weeks
- 12 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- -0.74
- Market Dynamics
- -0.53
Over the latest 12 completed weeks ending 2026-07-10, BIOG-B rose 2.19%, moving from 114.00 to 116.50. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is -0.74 and has improved across the 12-week window. Market Dynamics is -0.53 on the latest week. Next-week expectancy is undecided at 48.44% based on similar historical setup states.
Industry Peers
Sweden equities in Drug Manufacturers - Specialty & Generic
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| NEWBRY Newbury Pharmaceuticals AB (publ) | STO | 10 Jul 2026 | 2.06 | 2.50 | 1.22 | 2.42 | 17.48% |
| ENZY Enzymatica AB (publ) | STO | 10 Jul 2026 | 2.27 | 2.60 | 2.21 | 2.48 | 9.25% |
| CINPHA Cinclus Pharma Holding AB (publ) | STO | 10 Jul 2026 | 11.28 | 12.20 | 11.18 | 11.98 | 6.21% |
| NANEXA Nanexa AB (publ) | STO | 10 Jul 2026 | 3.57 | 3.73 | 3.53 | 3.70 | 3.64% |
| ACUC AcuCort AB | STO | 10 Jul 2026 | 0.62 | 0.67 | 0.60 | 0.64 | 3.23% |
| MOB Moberg Pharma AB (publ) | STO | 10 Jul 2026 | 9.45 | 9.73 | 9.23 | 9.47 | 0.21% |
| PMED PEPTONIC Medical AB | STO | 10 Jul 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00% |
| VIVE Vivesto AB | STO | 10 Jul 2026 | 8.50 | 9.18 | 8.10 | 8.45 | -0.59% |
| EQL EQL Pharma AB | STO | 10 Jul 2026 | 23.60 | 24.30 | 22.30 | 23.35 | -1.06% |
| SOBI Swedish Orphan Biovitrum AB (publ) | STO | 10 Jul 2026 | 480.00 | 487.00 | 470.60 | 471.20 | -1.83% |
| KLAR Klaria Pharma Holding AB (publ.) | STO | 10 Jul 2026 | 0.78 | 0.85 | 0.74 | 0.76 | -2.31% |
| ORX Orexo AB (publ) | STO | 10 Jul 2026 | 24.40 | 25.35 | 22.50 | 23.20 | -4.92% |
| CRNO-B Cereno Scientific AB (publ) | STO | 10 Jul 2026 | 5.13 | 5.21 | 4.70 | 4.83 | -5.93% |
| ALVO-SDB Alvotech SDB | STO | 10 Jul 2026 | 35.80 | 36.45 | 32.30 | 33.55 | -6.28% |
| DICOT Dicot Pharma AB | STO | 10 Jul 2026 | 0.21 | 0.21 | 0.18 | 0.19 | -7.16% |
| ODI ODI Pharma AB | STO | 10 Jul 2026 | 2.56 | 3.00 | 2.12 | 2.30 | -10.16% |